PHVS – pharvaris n.v. - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PHVS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/3

12:16 pm

phvs

Pharvaris (PHVS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.

Low Report

Pharvaris (PHVS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.

Report

3/2

07:09 am

phvs

Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026 [Yahoo! Finance]

Low Report

Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026 [Yahoo! Finance]

Report

3/2

06:50 am

phvs

Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026

Low Report

Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026

Report

2/28

01:30 am

phvs

Pharvaris (PHVS) was downgraded by Wall Street Zen from "hold" to "se

Low Report

Pharvaris (PHVS) was downgraded by Wall Street Zen from "hold" to "se

Report

2/10

07:02 am

phvs

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting [Yahoo! Finance]

Low Report

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting [Yahoo! Finance]

Report

2/10

06:50 am

phvs

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting

Low Report

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting

Report

2/7

02:07 am

phvs

Pharvaris (NASDAQ:PHVS) was upgraded by analysts at Wall Street Zen

Low Report

Pharvaris (NASDAQ:PHVS) was upgraded by analysts at Wall Street Zen

Report

1/17

09:48 pm

phvs

Assessing Pharvaris (PHVS) Valuation After Recent Share Price Volatility And DCF Upside Gap [Yahoo! Finance]

Medium Report

Assessing Pharvaris (PHVS) Valuation After Recent Share Price Volatility And DCF Upside Gap [Yahoo! Finance]

Report

1/17

01:11 am

phvs

Pharvaris (NASDAQ:PHVS) was downgraded by analysts at Wall Street Zen

Medium Report

Pharvaris (NASDAQ:PHVS) was downgraded by analysts at Wall Street Zen

Report

1/12

06:50 am

phvs

Pharvaris Outlines 2026 Strategic Priorities

Low Report

Pharvaris Outlines 2026 Strategic Priorities

Report

1/3

01:08 am

phvs

Pharvaris (NASDAQ:PHVS) was upgraded by analysts at Wall Street Zen

Medium Report

Pharvaris (NASDAQ:PHVS) was upgraded by analysts at Wall Street Zen

Report

12/21

10:19 am

phvs

What Does Wall Street Think About Pharvaris N.V. (PHVS)? [Yahoo! Finance]

Medium Report

What Does Wall Street Think About Pharvaris N.V. (PHVS)? [Yahoo! Finance]

Report

12/13

01:10 am

phvs

Pharvaris (NASDAQ:PHVS) was downgraded by analysts at Wall Street Zen

Medium Report

Pharvaris (NASDAQ:PHVS) was downgraded by analysts at Wall Street Zen

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.